Cdk Inhibitors

CDK Inhibitors is a class of regulatory proteins that function as negative regulators of the cell cycle by specifically binding to and inhibiting cyclin-dependent kinase complexes, thereby preventing aberrant cell proliferation.

3.1K

Publications

251.8K

Citations

19.2K

Authors

2.9K

Institutions

Publications per year

2017–2026

904

Authors

19.2K

  1. LM
    Laurent Meijer

    Station Biologique de Roscoff, France

    61 publications · 9.5K citations

    43

    h-index

  2. NS
    Nathanael S. Gray

    Dana-Farber Cancer Institute, United States

    39 publications · 6.1K citations

    31

    h-index

  3. PM
    Peter M. Fischer

    University of Nottingham, United Kingdom

    23 publications · 1.7K citations

    20

    h-index

  4. SW
    Shudong Wang

    University of South Australia, Australia

    24 publications · 1.5K citations

    19

    h-index

  5. YX
    Yue Xiong

    University of North Carolina at Chapel Hill, United States

    18 publications · 3.2K citations

    18

    h-index

1–5 of 19.2K

Venues

  1. Journal of Biological Chemistry

    JBC · 123 publications · 11.8K citations

    64

    h-index

  2. Molecular and Cellular Biology

    MCB · 74 publications · 10.8K citations

    56

    h-index

  3. Journal of Medicinal Chemistry

    92 publications · 8.1K citations

    56

    h-index

  4. PubMed

    Repository · 138 publications · 10.2K citations

    55

    h-index

  5. Proceedings of the National Academy of Sciences

    PNAS · 56 publications · 10.1K citations

    48

    h-index

1–5